sacituzumab govitecan for bladder cancer

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
sacituzumab govitecan for bladder cancer	0.04	0.3	2807	49	40
sacituzumab	1.06	0.1	4321	44	11
govitecan	0.55	0.8	7222	81	9
for	0.85	0.3	5208	7	3
bladder	0.63	0.6	1342	95	7
cancer	1.5	0.5	2879	58	6

Keyword	CPC	PCC	Volume	Score
sacituzumab govitecan for bladder cancer	0.5	0.5	4800	51
sacituzumab govitecan bc cancer	0.31	0.9	659	85
sacituzumab govitecan ovarian cancer	0.92	1	6233	100
sacituzumab govitecan breast cancer	0.8	0.5	7583	63
sacituzumab govitecan urothelial carcinoma	0.13	0.8	1363	41
sacituzumab govitecan clinical trial	1.66	0.9	9034	14
sacituzumab govitecan patient information	1.12	0.9	3630	54
sacituzumab govitecan breast cancer approval	0.85	0.8	9347	89
sacituzumab govitecan lung cancer	0.5	0.5	9185	32
what is sacituzumab govitecan	0.62	0.6	7367	21
sacituzumab govitecan prescribing information	0.63	0.6	788	2
is sacituzumab govitecan chemotherapy	1.76	0.6	291	66
sacituzumab govitecan fda label	1.71	0.9	781	10
sacituzumab govitecan fda approval	0.02	0.4	5739	47
sacituzumab govitecan drug class	0.22	0.7	5156	61
sacituzumab govitecan j code	1.51	0.8	8245	40
sacituzumab govitecan small cell lung cancer	1.76	0.6	9430	59
sacituzumab govitecan fiche patient	1.29	0.4	9930	10
sacituzumab govitecan mechanism of action	1.44	1	2619	43
sacituzumab govitecan-hziy	0.07	1	400	21
is sacituzumab govitecan immunotherapy	1.8	0.2	2584	14
sacituzumab govitecan plus pembrolizumab	0.24	0.6	7264	66